Darren Snellgrove
Vice President of Investor Relations
Replay available
Johnson & Johnson (JNJ) Q3 2025 Earnings Call
Johnson & Johnson (NYSE: JNJ) Q3 2025 earnings conference call, held 2025-10-14. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Joaquin Duarte
Chairman and CEO
Joe Wok
Chief Financial Officer
Tim Schmid
Executive Vice President, Worldwide Chairman, MedTech
Jennifer Talbot
Executive Vice President, Worldwide Chairman, Innovative Medicine
John Reed
Executive Vice President, Innovative Medicine Research and Development
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Johnson & Johnson.
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:04.756 Good morning and welcome to Johnson & Johnson's third quarter 2025 earnings conference 00:00:04.756 -- 00:00:09.040 call. All participants will be in the listen-only mode until the question and answer 00:00:09.040 -- 00:00:11.122 session of the conference. 00:00:11.122 -- 00:00:15.687 This call is being recorded. If anyone has any objections, you may disconnect at this 00:00:15.687 -- 00:00:20.351 time. If you experience technical difficulties during the conference, you may press star 00:00:20.351 -- 00:00:22.774 zero to reach for the operator. 00:00:22.774 -- 00:00:25.276 I will now turn the conference call over to Johnson & Johnson. 00:00:25.276 -- 00:00:27.537 You may begin. 00:00:28.212 -- 00:00:32.777 Hello, everyone. This is Darren Snellgrove, Vice President of Investor Relations for 00:00:32.777 -- 00:00:37.802 Johnson & Johnson. Welcome to our 2025 third quarter review of 00:00:37.802 -- 00:00:41.285 business results and updated financial outlook. 00:00:41.285 -- 00:00:43.368 First, a few logistics. 00:00:43.368 -- 00:00:48.373 As a reminder, today's presentation and associated schedules are available on the 00:00:48.373 -- 00:00:54.317 Investor Relations section of the Johnson & Johnson website at investor.jnj.com. 00:00:55.567 -- 00:01:00.977 Please note that this presentation contains forward-looking statements regarding, among 00:01:00.977 -- 00:01:06.907 other things, the company's future operating and financial performance, market position, 00:01:06.907 -- 00:01:12.277 and business strategy. You are cautioned not to rely on these forward-looking statements, 00:01:12.277 -- 00:01:17.767 which are based on the current expectations of future events using the information available 00:01:17.767 -- 00:01:23.551 as of the da...